Showing results (701-710 of 825) with videos related to

Sort By:
Pageof 83
Thrombosis Research|February 12, 2008
Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein EMartijn C G J Brouwers, Jose Govers-Riemslag, Casper G Schalkwijk, et al.
Diabetes, Obesity & Metabolism|July 17, 2025
Prediction of glycaemic control and quality of life in people with type 2 diabetes using glucose-lowering drugs with machine learning-The Maastricht studyNikki C C Werkman, Johannes T H Nielen, José Tapia-Galisteo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 12, 2014
Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistanceKatrien H J Gaens, Gijs H Goossens, Petra M Niessen, et al.
Acta Ophthalmologica|February 5, 2020
Reduced corneal nerve fibre length in prediabetes and type 2 diabetes: The Maastricht StudyEline E B De Clerck, Jan S A G Schouten, Tos T J M Berendschot, et al.
Diabetologia|August 7, 2020
The association of hyperglycaemia and insulin resistance with incident depressive symptoms over 4 years of follow-up: The Maastricht StudyAnouk F J Geraets, Sebastian Köhler, Rutendo Muzambi, et al.
Diabetologia|June 16, 2020
Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht StudyJeroen H P M van der Velde, Annemarie Koster, Elsa S Strotmeyer, et al.
Circulation|September 29, 2016
Prediabetes and Type 2 Diabetes Are Associated With Generalized Microvascular Dysfunction: The Maastricht StudyBen M Sörensen, Alfons J H M Houben, Tos T J M Berendschot, et al.
European Journal of Endocrinology|July 4, 2015
BclI glucocorticoid receptor polymorphism in relation to cardiovascular variables: the Hoorn and CODAM studiesDirk van Moorsel, Marleen M J van Greevenbroek, Nicolaas C Schaper, et al.
Diabetes, Obesity & Metabolism|February 16, 2021
Metformin and carotid intima-media thickness in never-smokers with type 1 diabetes: The REMOVAL trialJoseph G Timmons, Nicola Greenlaw, James G Boyle, et al.
BMC Public Health|November 8, 2012
The Diabetes Pearl: Diabetes biobanking in The NetherlandsEsther van't Riet, Miranda T Schram, Evertine J Abbink, et al.
Pageof 83